Prevalence of clinically actionable genotypes and medication exposure of older adults in the community
Nilofar Daneshi,1,2 Elizabeth Holliday,3,4 Stephen Hancock,3,4 Jennifer J Schneider,1,2 Rodney J Scott,1,2,5 John Attia,3,4 Elizabeth A Milward1,2 1Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, 2Faculty of Health and Medicine, Centre for Bioinformatics, Biomarker Discov...
Main Authors: | Daneshi N, Holliday E, Hancock S, Schneider JJ, Scott RJ, Attia J, Milward EA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-01-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/prevalence-of-clinically-actionable-genotypes-and-medication-exposure--peer-reviewed-article-PGPM |
Similar Items
-
Emerging strategies and applications of pharmacogenomics
by: Milos Patrice M, et al.
Published: (2004-11-01) -
Practical Barriers and Facilitators Experienced by Patients, Pharmacists and Physicians to the Implementation of Pharmacogenomic Screening in Dutch Outpatient Hospital Care—An Explorative Pilot Study
by: Pauline Lanting, et al.
Published: (2020-12-01) -
Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping
by: Amber Frick, et al.
Published: (2018-10-01) -
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma
by: Lydia Giannitrapani, et al.
Published: (2024-02-01) -
Genomic Evaluation of Colombian Holstein Cattle Using Imputed Genotypes at Medium Density
by: Juan C. Zambrano, et al.
Published: (2019-05-01)